Olshan Frome Wolosky LLP represented Summit Therapeutics in the offering. Summit Therapeutics Inc. (NASDAQ: SMMT) executed its rights offering of up to 14,312,977 shares of its...
Olshan Frome Wolosky LLP represented Summit Therapeutics in the offering. Summit Therapeutics Inc. (NASDAQ: SMMT) executed its rights offering of up to 14,312,977 shares of its...
You must be a Standard 1 Year member to access this content.